Ashish Dandekar Bought 32% More Shares In Camlin Fine Sciences

Camlin Fine Sciences Limited (NSE:CAMLINFINE) shareholders (or potential shareholders) will be happy to see that the Chairman & MD, Ashish Dandekar, recently bought a whopping ₹546m worth of stock, at a price of ₹114. Not only is that a big swing, but it increased their holding size by 32%, which is definitely great to see.

Check out our latest analysis for Camlin Fine Sciences

The Last 12 Months Of Insider Transactions At Camlin Fine Sciences

In fact, the recent purchase by Ashish Dandekar was the biggest purchase of Camlin Fine Sciences shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of ₹114. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Camlin Fine Sciences share holders is that an insider was buying at near the current price. Ashish Dandekar was the only individual insider to buy during the last year.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Camlin Fine Sciences is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Camlin Fine Sciences insiders own 16% of the company, worth about ₹3.1b. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Camlin Fine Sciences Insider Transactions Indicate?

The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Camlin Fine Sciences. Looks promising! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, Camlin Fine Sciences has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.

But note: Camlin Fine Sciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.